Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Leveraging the presence or absence of miRNA isoforms for recommending therapy in cancer patients

Leveraging the presence or absence of miRNA isoforms for recommending therapy in cancer patients

US Patent 11905563 · Granted Feb 20, 2024

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Systems-level analysis of 32 TCGA cancers reveals disease-dependent tRNA fragmen2023
Systems-level analysis of 32 TCGA cancers reveals disease-dependent tRNA fragmen2023
Compositions and methods of using RNA fragments2023
Human miRNAs for use in diagnosis, prognosis, and therapy of human conditions an2022
Ribonucleic acid interference molecules of Arabidopsis thaliana2014
Ribonucleic acid interference molecules of Oryza sativa2014
System and method for identification of microRNA target sites and corresponding 2013
Ribonucleic acid interference molecules2013
Method and apparatus for matching of bracketed patterns in test strings2012
Ribonucleic acid interference molecules and binding sites derived by analyzing i2012
Techniques for linking non-coding and gene-coding deoxyribonucleic acid sequence2011
Sequence pattern descriptors for transmembrane structural details2011